Does GLIMEPIRIDE Cause Hypovolaemia? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Hypovolaemia have been filed in association with GLIMEPIRIDE (Glimepiride). This represents 0.1% of all adverse event reports for GLIMEPIRIDE.
6
Reports of Hypovolaemia with GLIMEPIRIDE
0.1%
of all GLIMEPIRIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hypovolaemia From GLIMEPIRIDE?
Of the 6 reports, 5 (83.3%) required hospitalization, and 1 (16.7%) were considered life-threatening.
Is Hypovolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLIMEPIRIDE. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does GLIMEPIRIDE Cause?
Hypoglycaemia (1,403)
Blood glucose increased (446)
Acute kidney injury (339)
Drug ineffective (339)
Diarrhoea (257)
Blood glucose decreased (232)
Lactic acidosis (219)
Glycosylated haemoglobin increased (214)
Diabetes mellitus inadequate control (213)
Hypoglycaemic coma (187)
What Other Drugs Cause Hypovolaemia?
FUROSEMIDE (346)
METFORMIN (281)
EMPAGLIFLOZIN (150)
SPIRONOLACTONE (123)
DEXAMETHASONE (117)
HYDROCHLOROTHIAZIDE (94)
PREDNISONE (91)
LISINOPRIL (86)
METOPROLOL (84)
ACETAMINOPHEN (77)
Which GLIMEPIRIDE Alternatives Have Lower Hypovolaemia Risk?
GLIMEPIRIDE vs GLIMEPIRIDE\ROSIGLITAZONE
GLIMEPIRIDE vs GLIPIZIDE
GLIMEPIRIDE vs GLIVEC
GLIMEPIRIDE vs GLOFITAMAB
GLIMEPIRIDE vs GLOFITAMAB-GXBM